University of Cambridge > > Causal Inference Reading Group > Genetics-based drug discovery: Some stories from the frontline

Genetics-based drug discovery: Some stories from the frontline

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Qingyuan Zhao.

Human genetics has become an increasingly popular means of identifying modifiable therapeutic targets for disease. For the last 16 months, I have been working at a start-up that partners with biotech, venture capital and pharma companies to interrogate their drug candidates and identify new ones using human genetic and multi-omic data. This experience has sharpened my perspective on the value of human genetics in this space. I will share some projects from the last year that I believe highlight the scientific (and, in some cases, very human) challenges and potential of genetics-based drug discovery. Any client confidential information will be withheld to ensure compliance with all relevant CDAs.

This talk is part of the Causal Inference Reading Group series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity